BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2908120)

  • 21. Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats.
    Petersen H; Solomon T; Grossman MI
    Am J Physiol; 1978 Mar; 234(3):E286-93. PubMed ID: 343601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of atropine on pancreatic response to bethanechol, cholecystokinin, and food intake in rats.
    O'Rourke MF; Reidelberger RD; Solomon TE
    Am J Physiol; 1991 Nov; 261(5 Pt 1):G735-41. PubMed ID: 1683164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interdigestive and postprandial pancreatic exocrine secretion and cholecystokinin release in dogs].
    Huang YS; Huang TJ; Inoue K; Hosotani R; Kogire M; Tobe T; Rayford PL
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jul; 8(7):366-73. PubMed ID: 1433441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of pentagastrin on the lower esophageal sphincter.
    Zwick R; Bowes KL; Daniel EE; Sarna SK
    J Clin Invest; 1976 Jun; 57(6):1644-51. PubMed ID: 932198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atropine and naloxone block the colonic contraction elicited by cholecystokinin and pentagastrin.
    Hellström PM
    Acta Physiol Scand; 1985 May; 124(1):25-33. PubMed ID: 4013785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extrapancreatic cholinergic nerves mediate cholecystokinin-stimulated pancreatic polypeptide release.
    Kuvshinoff BW; Brodish RJ; Fink AS; McFadden DW
    J Surg Res; 1994 May; 56(5):397-401. PubMed ID: 8170138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of neurotensin, secretin and cholecystokinin on pancreatic exocrine secretion in conscious dogs.
    Sakamoto T; Fujimura M; Townsend CM; Greeley GH; Thompson JC
    Surg Gynecol Obstet; 1988 Jan; 166(1):11-6. PubMed ID: 3336811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function.
    Tachibana I; Kanagawa K; Yamamoto Y; Otsuki M
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1404-12. PubMed ID: 8968365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin- and gastrin-induced protein and amylase secretion from the parotid gland of the anaesthetized rat.
    Aras HC; Ekström J
    Regul Pept; 2006 May; 134(2-3):89-96. PubMed ID: 16515811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent pancreatotrophic effect of cholecystokinin-octapeptide in the rat: the influence of starvation.
    Nagy I; Lászik Z; Mohácsi G
    Pharmacol Res; 1998 Apr; 37(4):309-19. PubMed ID: 9634648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intraduodenal administration of tarazepide on pancreatic secretion and duodenal EMG in neonatal calves.
    Zabielski R; Leśniewska V; Borlak J; Gregory PC; Kiela P; Pierzynowski SG; Barej W
    Regul Pept; 1998 Nov; 78(1-3):113-23. PubMed ID: 9879754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative comparison of the effects of cholecystokinin, secretin, and pentagastrin on gastrointestinal myoelectric activity in the conscious fasted dog.
    Wingate DL; Pearce EA; Hutton M; Dand A; Thompson HH; Wünsch E
    Gut; 1978 Jul; 19(7):593-601. PubMed ID: 680593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of colonic contractility to cholecystokinin and other peptides.
    Mangel AW
    Eur J Pharmacol; 1984 May; 100(3-4):285-90. PubMed ID: 6203762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms involved in the control of exocrine pancreatic secretion in the interdigestive state in the rabbit.
    Montero A; Bragado J; Alonso RM; García LJ; Calvo JJ; López MA
    Rev Esp Fisiol; 1993 Jun; 49(2):93-9. PubMed ID: 8104355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
    Chey WY; Lee KY; Chang TM; Chen YF; Millikan L
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa.
    Johnson LR; Guthrie P
    Gastroenterology; 1976 Jan; 70(1):59-65. PubMed ID: 1245285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cholecystokinin and pentagastrin on motility and gastric secretion in the cat.
    Desvigne C; Gelin ML; Vagne M; Roche M
    Digestion; 1980; 20(4):265-76. PubMed ID: 6248406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
    Yoshida H; Tsunoda Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G735-47. PubMed ID: 9316479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinergic dependence of gallbladder response to cholecystokinin in the guinea pig in vivo.
    Takahashi T; May D; Owyang C
    Am J Physiol; 1991 Oct; 261(4 Pt 1):G565-9. PubMed ID: 1681736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supramaximal CCK-58 does not induce pancreatitis in the rat: role of pancreatic water secretion.
    Yamamoto M; Reeve JR; Green GM
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G964-74. PubMed ID: 17158258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.